Copper metabolism-related biomarkers and therapeutic targets for diabetic nephropathy
Qiaofang Yan, Yuanyuan Du, Fei Huang, Min Zhan, Qifan Zheng, Qiaoxuan Zhang, Pengwei Zhang, Jun Yan, Xiaobin Wu, Haibiao Lin, Xianzhang Huang, Liqiao Han · 2025
Read Copper metabolism-related biomarkers and therapeutic targets for diabetic nephropathy by Qiaofang Yan, Yuanyuan Du, Fei Huang, Min Zhan, Qifan Zheng, Qiaoxuan Zhang, Pengwei Zhang, Jun Yan, Xiaobin Wu, Haibiao Lin, Xianzhang Huang, Liqiao Han (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12721120.txt.
Description
Qiaofang Yan and co-authors hunt for early warning signs of diabetic kidney disease in a 2025 study. The disease, also called diabetic nephropathy, is the hardest complication of diabetes to manage, and doctors still lack sharp tests and strong drugs for it. Odd copper handling in the body has been tied to diabetes, so the team focused on genes linked to copper.
Working from public gene data sets, the team found five copper-linked genes that behaved differently in diseased tissue. Used together, the five markers picked out the disease with good accuracy, and some tracked how well the kidneys still filtered blood. The markers also lined up with immune cell patterns in the tissue. A drug database search turned up fifteen compounds that act on these genes, giving future treatment studies a place to start.
Catalog record
| CREATOR | Qiaofang Yan, Yuanyuan Du, Fei Huang, Min Zhan, Qifan Zheng, Qiaoxuan Zhang, Pengwei Zhang, Jun Yan, Xiaobin Wu, Haibiao Lin, Xianzhang Huang, Liqiao Han |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |